Shares of Addus HomeCare Corporation (NASDAQ:ADUS - Get Free Report) have been given a consensus rating of "Moderate Buy" by the eleven ratings firms that are presently covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, two have issued a hold rating, seven have issued a buy rating and one has given a strong buy rating to the company. The average twelve-month target price among brokerages that have updated their coverage on the stock in the last year is $133.2222.
A number of research firms have recently issued reports on ADUS. Weiss Ratings restated a "hold (c+)" rating on shares of Addus HomeCare in a research report on Wednesday, January 21st. Wall Street Zen lowered Addus HomeCare from a "strong-buy" rating to a "buy" rating in a research note on Saturday, March 21st. Royal Bank Of Canada restated an "outperform" rating and issued a $139.00 target price on shares of Addus HomeCare in a report on Wednesday, February 25th. Truist Financial set a $135.00 target price on Addus HomeCare and gave the stock a "buy" rating in a research note on Wednesday, January 7th. Finally, Barclays reduced their price target on Addus HomeCare from $112.00 to $102.00 and set an "underweight" rating on the stock in a report on Wednesday.
View Our Latest Stock Analysis on ADUS
Addus HomeCare Stock Down 1.7%
Shares of NASDAQ ADUS opened at $97.67 on Friday. The stock has a market cap of $1.82 billion, a PE ratio of 18.75, a P/E/G ratio of 1.38 and a beta of 0.92. The company has a current ratio of 1.80, a quick ratio of 1.80 and a debt-to-equity ratio of 0.11. Addus HomeCare has a 12-month low of $94.86 and a 12-month high of $124.43. The company has a 50-day moving average of $106.00 and a 200 day moving average of $111.21.
Insider Activity
In other news, EVP David W. Tucker sold 379 shares of the stock in a transaction that occurred on Wednesday, February 25th. The shares were sold at an average price of $105.36, for a total value of $39,931.44. Following the completion of the sale, the executive vice president owned 10,423 shares of the company's stock, valued at $1,098,167.28. This represents a 3.51% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, EVP Roberton James Stevenson sold 284 shares of the firm's stock in a transaction that occurred on Wednesday, February 25th. The stock was sold at an average price of $105.36, for a total transaction of $29,922.24. Following the sale, the executive vice president owned 14,030 shares of the company's stock, valued at $1,478,200.80. This represents a 1.98% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 16,610 shares of company stock valued at $1,768,970 in the last quarter. Insiders own 4.50% of the company's stock.
Institutional Inflows and Outflows
Several hedge funds have recently added to or reduced their stakes in the business. Hsbc Holdings PLC increased its stake in Addus HomeCare by 57.5% during the fourth quarter. Hsbc Holdings PLC now owns 7,860 shares of the company's stock worth $847,000 after acquiring an additional 2,870 shares during the last quarter. Caitong International Asset Management Co. Ltd lifted its stake in shares of Addus HomeCare by 73.8% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 325 shares of the company's stock valued at $35,000 after purchasing an additional 138 shares during the last quarter. Invesco Ltd. lifted its stake in shares of Addus HomeCare by 7.1% in the 4th quarter. Invesco Ltd. now owns 416,857 shares of the company's stock valued at $44,766,000 after purchasing an additional 27,683 shares during the last quarter. Caitlin John LLC purchased a new position in shares of Addus HomeCare during the 4th quarter worth $183,000. Finally, Empowered Funds LLC grew its holdings in shares of Addus HomeCare by 186.1% during the 4th quarter. Empowered Funds LLC now owns 70,927 shares of the company's stock worth $7,617,000 after purchasing an additional 46,137 shares during the period. 95.35% of the stock is currently owned by hedge funds and other institutional investors.
About Addus HomeCare
(
Get Free Report)
Addus HomeCare NASDAQ: ADUS is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients' independence and quality of life.
The company's core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Addus HomeCare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.
While Addus HomeCare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.